Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorFedotkina, Olena
dc.contributor.authorJain, Ruchi
dc.contributor.authorPrasad, Rashmi B.
dc.contributor.authorLuk, Andrea
dc.contributor.authorGarcía Ramírez, Marta
dc.contributor.authorOzgumus, Turkuler
dc.contributor.authorSimó Canonge, Rafael
dc.date.accessioned2022-09-09T08:24:03Z
dc.date.available2022-09-09T08:24:03Z
dc.date.issued2022-05-05
dc.identifier.citationFedotkina O, Jain R, Prasad RB, Luk A, García-Ramírez M, Özgümüs T, et al. Neuronal Dysfunction Is Linked to the Famine-Associated Risk of Proliferative Retinopathy in Patients With Type 2 Diabetes. Front Neurosci. 2022 May 5;16:858049.
dc.identifier.issn1662-453X
dc.identifier.urihttps://hdl.handle.net/11351/8096
dc.descriptionRetinopatia diabètica; Fam; Funció neuronal
dc.description.sponsorshipThis work was supported by the Swedish Research Council (Dnr2015-03574 and Dnr349-2006-237), Strategic Research Area Exodiab (Dnr2009-1039), the Novonordisk Foundation (NNF12OC1016467), Swedish Foundation for Strategic Research (DnrIRC15-0067), the Steno Diabetes Center Copenhagen, Bergen Research Foundation and Trond Mohn Foundation (BFS811294), and the University of Bergen.
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Neuroscience;16
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectDiabetis no-insulinodependent - Complicacions
dc.subjectRetinopatia diabètica
dc.subjectSistema nerviós - Malalties
dc.subject.meshDiabetic Retinopathy
dc.subject.meshNerve Degeneration
dc.subject.meshDiabetes Mellitus, Type 2
dc.titleNeuronal Dysfunction Is Linked to the Famine-Associated Risk of Proliferative Retinopathy in Patients With Type 2 Diabetes
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3389/fnins.2022.858049
dc.subject.decsretinopatía diabética
dc.subject.decsdegeneración nerviosa
dc.subject.decsdiabetes mellitus tipo II
dc.relation.publishversionhttps://doi.org/10.3389/fnins.2022.858049
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Fedotkina O, Özgümüs T] Department of Clinical Science, Center for Diabetes Research, University of Bergen, Bergen, Norway. [Jain R, Prasad RB] Department of Clinical Sciences, Lund University Diabetes Center, Skane University Hospital, Malmö, Sweden. [Luk A] Prince of Wales Hospital, Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China. [García-Ramírez M, Simo R] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBERDEM, Barcelona, Spain
dc.identifier.pmid35600617
dc.identifier.wos000798022600001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple